Linda L. Bauer

Linda L. Bauer has extensive experience in medical and scientific writing. Linda L. is currently the Director of Medical Writing at Arena Pharmaceuticals, Inc, a position they have held since 2022. Prior to this, they were the Associate Director of Medical and Scientific Writing at the same company from 2018. Linda also worked as a Lead Medical Writer at MedImmune from 2008 to 2018, where they were responsible for various writing tasks related to clinical trial data analysis and regulatory documentation. Before that, they held positions as a Regulatory Writing Senior Manager at Amgen in 2007, a Contract Medical Writer at the Bill & Melinda Gates Foundation from 2006 to 2008, a Senior Medical Writer at ICOS Corporation from 2005 to 2007, a Medical Writer II at Amylin Pharmaceuticals from 2003 to 2005, an Associate Medical Writer II at IDEC Pharmaceuticals Corp from 2002 to 2003, and an Associate Medical Writer at Neurocrine Biosciences from 2000 to 2002.

Linda L. Bauer holds a Master's degree in English from National University (PH), which they obtained from 2001 to 2004. Linda L. also completed coursework in critical thinking, scientific thinking, and Socratic reasoning at the Foundation for Critical Thinking. Prior to this, they earned a BA in Literatures in English from the University at Albany, SUNY. Linda also has professional certificates in Copyediting and Substantive Editing from UC San Diego, as well as a Professional Certificate in Scientific and Technical Writing from San Diego State University. Linda L.'searlier education includes a BS in Nursing from Beth Israel Medical Center School of Nursing, completed in 1982.